These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28072829)

  • 1. Predicting the Metabolic Sites by Flavin-Containing Monooxygenase on Drug Molecules Using SVM Classification on Computed Quantum Mechanics and Circular Fingerprints Molecular Descriptors.
    Fu CW; Lin TH
    PLoS One; 2017; 12(1):e0169910. PubMed ID: 28072829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors.
    Xia Z; Yan A
    Mol Divers; 2017 Aug; 21(3):661-675. PubMed ID: 28484935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR and QSAR models of cyclooxygenase-1 (COX-1) inhibitors.
    Xi Y; Qin Z; Yan A
    SAR QSAR Environ Res; 2018 Oct; 29(10):755-784. PubMed ID: 30274533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer modeling in predicting the bioactivity of human 5-lipoxygenase inhibitors.
    Zhang M; Xia Z; Yan A
    Mol Divers; 2017 Feb; 21(1):235-246. PubMed ID: 27904990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of bioactivity of ACAT2 inhibitors by multilinear regression analysis and support vector machine.
    Zhong M; Xuan S; Wang L; Hou X; Wang M; Yan A; Dai B
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3788-92. PubMed ID: 23711921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
    Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
    Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some distinctions between flavin-containing and cytochrome P450 monooxygenases.
    Cashman JR
    Biochem Biophys Res Commun; 2005 Dec; 338(1):599-604. PubMed ID: 16112078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.
    Krueger SK; Williams DE
    Pharmacol Ther; 2005 Jun; 106(3):357-87. PubMed ID: 15922018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral metabolism of imipramine and a purified flavin-containing monooxygenase from human brain.
    Bhagwat SV; Bhamre S; Boyd MR; Ravindranath V
    Neuropsychopharmacology; 1996 Aug; 15(2):133-42. PubMed ID: 8840349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utilisation of structural descriptors to predict metabolic constants of xenobiotics in mammals.
    Pirovano A; Brandmaier S; Huijbregts MA; Ragas AM; Veltman K; Hendriks AJ
    Environ Toxicol Pharmacol; 2015 Jan; 39(1):247-58. PubMed ID: 25531263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAR study on inhibitors of GIIA secreted phospholipase A
    Zhang S; Li Y; Qin Z; Tu G; Chen G; Yan A
    Chem Biol Drug Des; 2019 May; 93(5):666-684. PubMed ID: 30582300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of flavin-containing monooxygenase in drug development.
    Cashman JR
    Expert Opin Drug Metab Toxicol; 2008 Dec; 4(12):1507-21. PubMed ID: 19040327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of cytochrome P450 1A2 inhibitors and noninhibitors by machine learning techniques.
    Vasanthanathan P; Taboureau O; Oostenbrink C; Vermeulen NP; Olsen L; Jørgensen FS
    Drug Metab Dispos; 2009 Mar; 37(3):658-64. PubMed ID: 19056915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAME 2: Simple and Effective Machine Learning Model of Cytochrome P450 Regioselectivity.
    Šícho M; de Bruyn Kops C; Stork C; Svozil D; Kirchmair J
    J Chem Inf Model; 2017 Aug; 57(8):1832-1846. PubMed ID: 28782945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Support Vector Machine (SVM) Models for Predicting Inhibitors of the 3' Processing Step of HIV-1 Integrase.
    Xuan S; Wang M; Kang H; Kirchmair J; Tan L; Yan A
    Mol Inform; 2013 Oct; 32(9-10):811-26. PubMed ID: 27480234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavin-containing monooxygenase activity can be inhibited by nitric oxide-mediated S-nitrosylation.
    Ryu SD; Yi HG; Cha YN; Kang JH; Kang JS; Jeon YC; Park HK; Yu TM; Lee JN; Park CS
    Life Sci; 2004 Oct; 75(21):2559-72. PubMed ID: 15363661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression.
    Hines RN; Cashman JR; Philpot RM; Williams DE; Ziegler DM
    Toxicol Appl Pharmacol; 1994 Mar; 125(1):1-6. PubMed ID: 8128486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SVM prediction of ligand-binding sites in bacterial lipoproteins employing shape and physio-chemical descriptors.
    Kadam K; Prabhakar P; Jayaraman VK
    Protein Pept Lett; 2012 Nov; 19(11):1155-62. PubMed ID: 22587788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Organizing Map (SOM) and Support Vector Machine (SVM) Models for the Prediction of Human Epidermal Growth Factor Receptor (EGFR/ ErbB-1) Inhibitors.
    Kong Y; Qu D; Chen X; Gong YN; Yan A
    Comb Chem High Throughput Screen; 2016; 19(5):400-11. PubMed ID: 27074760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of Metabolism Prediction Models for CYP450 3A4, 2D6, and 2C9 Based on Microsomal Metabolic Reaction System.
    He SB; Li MM; Zhang BX; Ye XT; Du RF; Wang Y; Qiao YJ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27735849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.